IBDEI0YZ ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16432,1,3,0)
 ;;=3^Vascular Dementia w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,16432,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,16432,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,16433,0)
 ;;=F01.50^^64^749^31
 ;;^UTILITY(U,$J,358.3,16433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16433,1,3,0)
 ;;=3^Vascular Dementia w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,16433,1,4,0)
 ;;=4^F01.50
 ;;^UTILITY(U,$J,358.3,16433,2)
 ;;=^5003046
 ;;^UTILITY(U,$J,358.3,16434,0)
 ;;=A81.9^^64^749^6
 ;;^UTILITY(U,$J,358.3,16434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16434,1,3,0)
 ;;=3^Atypical Virus Infection of CNS,Unspec
 ;;^UTILITY(U,$J,358.3,16434,1,4,0)
 ;;=4^A81.9
 ;;^UTILITY(U,$J,358.3,16434,2)
 ;;=^5000414
 ;;^UTILITY(U,$J,358.3,16435,0)
 ;;=A81.09^^64^749^8
 ;;^UTILITY(U,$J,358.3,16435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16435,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease NEC
 ;;^UTILITY(U,$J,358.3,16435,1,4,0)
 ;;=4^A81.09
 ;;^UTILITY(U,$J,358.3,16435,2)
 ;;=^5000410
 ;;^UTILITY(U,$J,358.3,16436,0)
 ;;=A81.00^^64^749^9
 ;;^UTILITY(U,$J,358.3,16436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16436,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Unspec
 ;;^UTILITY(U,$J,358.3,16436,1,4,0)
 ;;=4^A81.00
 ;;^UTILITY(U,$J,358.3,16436,2)
 ;;=^5000409
 ;;^UTILITY(U,$J,358.3,16437,0)
 ;;=A81.01^^64^749^10
 ;;^UTILITY(U,$J,358.3,16437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16437,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Variant
 ;;^UTILITY(U,$J,358.3,16437,1,4,0)
 ;;=4^A81.01
 ;;^UTILITY(U,$J,358.3,16437,2)
 ;;=^336701
 ;;^UTILITY(U,$J,358.3,16438,0)
 ;;=A81.89^^64^749^7
 ;;^UTILITY(U,$J,358.3,16438,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16438,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
 ;;^UTILITY(U,$J,358.3,16438,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,16438,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,16439,0)
 ;;=A81.2^^64^749^27
 ;;^UTILITY(U,$J,358.3,16439,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16439,1,3,0)
 ;;=3^Progressive Multifocal Leukoencephalopathy
 ;;^UTILITY(U,$J,358.3,16439,1,4,0)
 ;;=4^A81.2
 ;;^UTILITY(U,$J,358.3,16439,2)
 ;;=^5000411
 ;;^UTILITY(U,$J,358.3,16440,0)
 ;;=B20.^^64^749^17
 ;;^UTILITY(U,$J,358.3,16440,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16440,1,3,0)
 ;;=3^HIV Disease w/ Dementia w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,16440,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,16440,2)
 ;;=^5000555^F02.81
 ;;^UTILITY(U,$J,358.3,16441,0)
 ;;=B20.^^64^749^18
 ;;^UTILITY(U,$J,358.3,16441,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16441,1,3,0)
 ;;=3^HIV Disease w/ Dementia w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,16441,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,16441,2)
 ;;=^5000555^F02.80
 ;;^UTILITY(U,$J,358.3,16442,0)
 ;;=F10.27^^64^749^1
 ;;^UTILITY(U,$J,358.3,16442,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16442,1,3,0)
 ;;=3^Alc Dep w/ Alc-Induced Persist Dementia
 ;;^UTILITY(U,$J,358.3,16442,1,4,0)
 ;;=4^F10.27
 ;;^UTILITY(U,$J,358.3,16442,2)
 ;;=^5003095
 ;;^UTILITY(U,$J,358.3,16443,0)
 ;;=F19.97^^64^749^29
 ;;^UTILITY(U,$J,358.3,16443,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16443,1,3,0)
 ;;=3^Psychoactive Substance Use w/ Persisting Dementia NEC
 ;;^UTILITY(U,$J,358.3,16443,1,4,0)
 ;;=4^F19.97
 ;;^UTILITY(U,$J,358.3,16443,2)
 ;;=^5003465
 ;;^UTILITY(U,$J,358.3,16444,0)
 ;;=G30.0^^64^749^2
 ;;^UTILITY(U,$J,358.3,16444,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16444,1,3,0)
 ;;=3^Alzheimer's Disease w/ Early Onset
 ;;^UTILITY(U,$J,358.3,16444,1,4,0)
 ;;=4^G30.0
 ;;^UTILITY(U,$J,358.3,16444,2)
 ;;=^5003805
